Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE ‐158 and KEYNOTE ‐028 studies

A. Piha‐Paul, Sarina; Oh, Do‐Youn; Ueno, Makoto; Malka, David; Cheol Chung, Hyun; Nagrial, Adnan; Kate Kelley, Robin; Ros, Willeke; Italiano, Antoîne; Nakagawa, Kazuhiko; S. Rugo, Hope; de Braud, Filippo; Varga, Andréa; R. Hansen, Aaron; Wang, Hui; Krishnan, Suba; Norwood, Kevin; Doi, Toshihiko

doi:10.1002/ijc.33013

Public

Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE ‐158 and KEYNOTE ‐028 studies

Published in International Journal of Cancer • May 2, 2020

Authors:

Sarina A. Piha‐Paul

Do‐Youn Oh

Makoto Ueno

Abstract

We present data from patients with advanced biliary tract cancer (BTC) receiving pembrolizumab in the KEYNOTE-158 (NCT02628067; phase 2) and KEYNOTE-028 (NCT02054806; phase 1b) studies. Eligible patients aged ≥18 years from both studies had histologically/cytologically confirmed incurable BTC that p...

Subject

Pembrolizumab

Medicine

Cancer

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!